Cargando…

ETV6–NTRK3-positive parotid mammary analogue secretory carcinoma: a case report

Introduction: Mammary analogue secretory carcinoma (MASC) is a recent discovered entity of salivary glands tumors, reported for first time in 2010. The presence of a translocation encodes the ETS variant transcription factor 6–neurotrophic tyrosine receptor kinase (ETV6–NTRK3) gene fusion difference...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cobo, Juan Rodríguez, Fernández, Servando Lazuén, Fernández, Marta María Mayorga, Román, Javier Gómez, Salinas, Javier Freire, Duque, María Soledad Rodríguez, Secadas, Carmen Vallejo, Gama, Javier Álvarez, Fidalgo, Eduardo Ibaseta, Medina del Valle, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597390/ https://www.ncbi.nlm.nih.gov/pubmed/34609437 http://dx.doi.org/10.47162/RJME.62.1.34

Ejemplares similares

NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report
por: AlKaabba, Fahad, et al.
Publicado: (2022)

Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature
por: Arce, C, et al.
Publicado: (2005)

A Pediatric Case of High-Grade Secretory Carcinoma of the Maxillary Sinus With ETV6::NTRK3 Gene Fusion, Therapeutic Implications, and Review of the Literature
por: Cardoni, Antonello, et al.
Publicado: (2022)

Secretory carcinoma of major and minor salivary glands with ETV6-NTRK3 gene fusion: overcoming misdiagnosis in the era of tumour-agnostic therapy with TRK inhibitors
por: Durzyńska, Monika, et al.
Publicado: (2023)

High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology
por: Klubíčková, Natálie, et al.
Publicado: (2023)

The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib
por: Papusha, Ludmila, et al.
Publicado: (2021)

Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report
por: Wagner, Florian, et al.
Publicado: (2021)

Secretory carcinoma in the parotid gland of a pediatric patient. A challenging diagnosis
por: Ash, Javier, et al.
Publicado: (2023)

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
por: Drilon, A., et al.
Publicado: (2016)

Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
por: Alharbi, Musa, et al.
Publicado: (2020)

The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations
por: Kinnunen, Matias, et al.
Publicado: (2023)

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
por: Yu, Qing-Xiang, et al.
Publicado: (2023)

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
por: Kralik, Johanna M, et al.
Publicado: (2011)

Mechanisms of targeted therapy resistance in a pediatric glioma driven by ETV6-NTRK3 fusion
por: Keddy, Clare, et al.
Publicado: (2021)

An ETV6::NTRK3 fusion transcript in a core‐binding factor acute myeloid leukemia
por: Coster, Lucie, et al.
Publicado: (2023)

Infantile Fibrosarcoma With NTRK3–ETV6 Fusion Successfully Treated With the Tropomyosin‐Related Kinase Inhibitor LOXO‐101
por: Nagasubramanian, Ramamoorthy, et al.
Publicado: (2016)

HGG-37. A case ofETV6-NTRK3 fusion driven infantile hemispheric glioma (IHG) with acquired drug resistance against first- and second-generation NTRK-inhibitors
por: Ku, Dennis T L, et al.
Publicado: (2022)

Complete response to larotrectinib treatment in a patient with papillary thyroid cancer harboring an ETV6‐NTRK3 gene fusion
por: Pitoia, Fabián
Publicado: (2021)

Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report
por: Takahashi, Akimasa, et al.
Publicado: (2018)

Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer
por: Moriyama, Etsuko, et al.
Publicado: (2023)

RADIOAUTOGRAPHIC ANALYSIS OF THE SECRETORY PROCESS IN THE PAROTID ACINAR CELL OF THE RABBIT
por: Castle, J. David, et al.
Publicado: (1972)

Mammary Analogue Secretory Carcinoma Arising in the Parotid Gland of Child
por: Shigeta, Rie, et al.
Publicado: (2018)

A short in-frame deletion in NTRK1 tyrosine kinase domain caused by a novel splice site mutation in a patient with congenital insensitivity to pain with anhidrosis
por: Sarasola, Esther, et al.
Publicado: (2011)

Metastasizing pleomorphic adenoma of the parotid gland
por: Soteldo, Javier, et al.
Publicado: (2017)

The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia
por: Rodríguez-Hernández, Guillermo, et al.
Publicado: (2021)

A case report of parotid mammary analogue secretory carcinoma and reviews
por: Sun, Luona, et al.
Publicado: (2019)

Mammary analogue secretory carcinoma presenting as a cystic parotid mass
por: Gupta, Karisma, et al.
Publicado: (2019)

Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement
por: Majewska, Hanna, et al.
Publicado: (2014)

Parotid mammary analogue secretory carcinoma: A case report and review of literature
por: Min, Feng-He, et al.
Publicado: (2021)

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
por: Bielack, S S, et al.
Publicado: (2019)

Expression of the neurotrophic tyrosine kinase receptors, ntrk1 and ntrk2a, precedes expression of other ntrk genes in embryonic zebrafish
por: Hahn, Katie, et al.
Publicado: (2020)

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions
por: Brčić, Iva, et al.
Publicado: (2020)

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5
por: Currie, Simon L., et al.
Publicado: (2017)

Secretion granules of the rabbit parotid. Selective removal of secretory contaminants from granule membranes
por: Castle, J. D., et al.
Publicado: (1978)

DYNAMIC CHANGES IN THE ULTRASTRUCTURE OF THE ACINAR CELL OF THE RAT PAROTID GLAND DURING THE SECRETORY CYCLE
por: Amsterdam, Avraham, et al.
Publicado: (1969)

CONCOMITANT SYNTHESIS OF MEMBRANE PROTEIN AND EXPORTABLE PROTEIN OF THE SECRETORY GRANULE IN RAT PAROTID GLAND
por: Amsterdam, Abraham, et al.
Publicado: (1971)

Mammary analog secretory carcinoma of the parotid gland: A case report and literature review.
por: Balanzá, Ricardo, et al.
Publicado: (2015)

A case of mammary analogue secretory carcinoma of the parotid gland: A case report
por: Kim, Seong Hwan, et al.
Publicado: (2020)

Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case report
por: Pircher, Magdalena, et al.
Publicado: (2021)

Long-term quality of life after ETV or ETV with consecutive VP shunt placement in hydrocephalic pediatric patients
por: Bogaczyk, Victoria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2166ob6m76l7966bp3c6oo562f